Normal age-dependent values of serum insulin growth factor-I: Results from a healthy Italian population

Journal of Endocrinological Investigation

Volumn 31, Issue 5, 2008, Pages 445-449

  Aimaretti, Gianluca ^a   Boschetti, M ^b   Corneli, G ^a   Gasco, V ^c   Valle, D ^d   Borsotti, M ^e   Rossi, A ^d   Barreca, A ^b   Fazzuoli, L ^b   Ferone, D ^b   Ghigo, E ^c   Minuto, F ^b  

^a UNIVERSITY OF EASTERN PIEDMONT   (Italy)

^b UNIVERSITY OF GENOA   (Italy)

^c UNIVERSITY OF TURIN   (Italy)

^d Eli Lilly Italia SpA   (Italy)

^e CAREGGI UNIVERSITY HOSPITAL   (Italy)

Author keywords

Healthy subjects; IGF I; Normal range

Indexed keywords

SOMATOMEDIN C;

ACROMEGALY; ADULT; AGE DISTRIBUTION; AGED; ARTICLE; BLOOD SAMPLING; CONTROLLED STUDY; CORRELATION COEFFICIENT; DIAGNOSTIC VALUE; FEMALE; GROWTH HORMONE DEFICIENCY; HUMAN; ITALY; MALE; NORMAL HUMAN; NORMAL VALUE; RADIOIMMUNOASSAY; REFERENCE VALUE;

EID: 48949117009     PISSN: 03914097     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF03346389     Document Type: Article

References (32)

1. Consensus guidelines for the diagnosis and treatment of adults with growth hormone deficiency: summary statement of the Growth Hormone Research Society Workshop on Adult Growth Hormone Deficiency. J Clin Endocrinol Metab 1998, 83: 379-81.
2. Pittoni G, Gallioi G, Zanello M, et al. Activity of GH/IGF-I axis in trauma and septic patients during artificial nutrition: different behavior patterns? J Endocrinol Invest 2002, 25: 214-23.
3. Aimaretti G, Baldelli R, Corneli G, et al. IGFs and IGFBPs in adult growth hormone deficiency. Endocr Dev 2005, 9: 76-88.
4. Frystyk J, Skjarbaek C, Vestbo E, Fisker S, Orskov H. Circulating levels of free insulin-like growth factors in obese subjects: the impact of type 2 diabetes. Diabetes Metab Res Rev 1999, 15: 314-22.
5. Wabitsch M, Blum WF, Muche R, et al. Insulin-like growth factors and their binding proteins before and after weight loss and their associations with hormonal and metabolic parameters in obese adolescent girls. Int J Obes Relat Metab Disord 1996, 20: 1073-80.
6. Juul A, Holm K, Kastrup KW, et al. Free insulin-like growth factor I serum levels in 1430 healthy children and adults, and its diagnostic value in patients suspected of growth hormone deficiency. J Clin Endocrinol Metab 1997, 82: 2497-502.
7. Juul A, Kastrup KW, Pedersen SA, Skakkebaek NE. Growth hormone (GH) provocative retesting of 108 young adults with childhood-onset GH deficiency and the diagnostic value of insulin-like growth factor I (IGF-1) and IGF-binding protein-3. J Clin Endocrinol Metab 1997, 82: 1195-201.
8. Hartman ML, Crowe BJ, Biller BM et al. Which patients do not require a GH stimulation test for the diagnosis of adult GH deficiency? J Clin Endocrinol Metab 2002, 87: 477-85.
9. Hilding A, Hall K, Wivall-Helleryd IL, Saaf M, Melin AL, Thoren M. Serum levels of insulin-like growth factor I in 152 patients with growth hormone deficiency, aged 19-82 years, in relation to those in healthy subjects. J Clin Endocrinol Metab 1999, 84: 2013-9.
10. Consensus guidelines for the diagnosis and treatment of growth hormone (GH) deficiency in childhood and adolescence. Summary statement of the GH Research Society. J Clin Endocrin Metab 2000, 85: 3990-3.
11. Clemmons DR. Clinical utility of measurements of insulin-like growth factor 1. Nat Clin Pract Endocrinol Metab 2006, 2: 436-46.
12. Massart C, Poirier JT. Serum insulin-like growth factor-I measurement in the follow-up of treated acromegaly: Comparison of four immunoassays. Clin Chim Acta 2006, 373: 176-9.
13. Fisker S, Jorgensen JO, Vahl N, Orskov H, Christiansen JS. Impact of gender and androgen status on IGF-I levels in normal and GH-deficient adults. Eur J Endocrinol 1999, 141: 601-8.
14. Mukherjee A, Monson JP, Jonsson PJ, Trainer PJ, Shalet SM; KIMS International Board. Seeking the optimal target range for insulin-like growth factor I during the treatment of adult growth hormone disorders. J Clin Endocrinol Metab 2003, 88: 5865-70.
15. Ghigo E, Aimaretti G, Maccario M, et al. Dose-response study of GH effects on circulating IGF-I and IGFBP-3 levels in healthy young men and women. Am J Physiol 1999, 276: 1009-13.
16. Granada ML, Murillo J, Lucas A, et al. Diagnostic efficiency of serum IGF-I, IGF-binding protein-3 (IGFBP-3), IGF-I/IGFBP-3 molar ratio and urinary GH measurements in the diagnosis of adult GH deficiency: importance of an appropriate reference population. Eur J Endocrinol 2000, 142: 243-53.
17. Nystrom FH, Ohman PK, Ekman BA, Osterlund MK, Karlberg BE, Arnqvist HJ. Population-based reference values for IGF-I and IGF-binding protein-1: relations with metabolic and anthropometric variables. Eur J Endocrinol 1997, 136: 165-72.
18. Juul A, Dalgaard P, Blum WF, et al. Serum levels of insulin-like growth factor (IGF)-binding protein-3 (IGFBP-3) in healthy infants, children, and adolescents: the relation to IGF-I, IGF-II, IGFBP-1, IGFBP-2, age, sex, body mass index, and pubertal maturation. J Clin Endocrinol Metab 1995, 80: 2534-42.
19. Brabant G, von zur Muhlen A, Wuster C, et al. Serum insulin-like growth factor I reference values for an automated chemiluminescence immunoassay system: results from a multicenter study. Horm Res 2003, 60: 53-60.
20. Lofqvist C, Andersson E, Gelander L, et al. Reference values for IGF-I throughout childhood and adolescence: a model that accounts simultaneously for the effect of gender, age, and puberty. J Clin Endocrinol Metab 2001, 86: 5870-6.
21. Corneli G, Rovere S, Croce CS, et al. Age related cut-off limits of Insulin-like growth factor (IGF)-I in the diagnostic screening of adult growth hormone deficit (A-GHD) using ROC plot analysis. XXXI National Congress of the Italian Society of Endocrinology, Magazzini del Cotone, Genoa (Italy), 4-7 May 2005. J Endocrinol Invest 2005, 28 (Suppl 4): PP227 (Abstract).
22. Daughaday WH, Mariz IK, Blethen SL. Inhibition of access of bound somatomedin to membrane receptor and immunoglobin sites: a comparison of radioreceptor and radioimmunoassay of somatomedin in native and acid-ethanol extracted serum. J Clin Endocrinol Metab 1980, 51: 781-8.
23. Bland JM, Altman DG. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet 1986, 1: 307-10
24. Thissen JP, Ketelslegers JM, Underwood LE. Nutritional regulation of the insulin-like growth factors. Endocr Rev 1994, 15: 80-101.
25. Unden AL, Elofsson S, Knox S, Lewitt MS, Brismar K. IGF-I in a normal population: relation to psychosocial factors. Clin Endocrinol (Oxf) 2002, 57: 793-803.
26. Landin-Wilhelmsen K, Lundberg PA, Lappas G, Wilhelmsen L. Insulin-like growth factor I levels in healthy adults. Horm Res 2004, 62 (Suppl 1): 8-16.
27. Tiryakioglu O, Kadiolgu P, Canerolgu NU, Hatemi H. Age dependency of serum insulin-like growth factor (IGF)-1 in healthy Turkish adolescents and adults. Indian J Med Sci 2003, 57: 543-8.
28. Kitano M, Shimizu T, Yamazaki Y, Umezu Y, Arakawa Y, Daimon Y. Serum insulin-like growth factor-I (IGF-I) in normal Japanese adults. Endocr J 1995, 42: 767-70.
29. McGreevy K, Hoel B, Lipsitz S, Bissada N, Hoel D. Racial and anthropometric differences in plasma levels of insulin-like growth factor I and insulin-like growth factor binding protein-3. Urology 2005, 66: 587-92.
30. Ranke MB, Osterziel KJ, Schweizer R, et al, Reference levels of insulin-like growth factor I in the serum of healthy adults: comparison of four immunoassays. Clin Chem Lab Med 2003, 41: 1329-34.
31. Ivan D, Brabant G, Kann PH; German KIMS Board. Applicability of recently established reference values for serum insulin-like growth factor 1: A comparison of two assays an (automated) chemiluminescence immunoassay and an enzyme-linked immunosorbent assay. Clin Lab 2005, 51: 381-7.
32. Blum WK, Breier BH. Radioimmunoassays for IGFs and IGFBPs. Growth Regul 1994, 4 (Suppl 1): 11-9.